Literature DB >> 21164130

Screening for intracranial aneurysm in 355 patients with autosomal-dominant polycystic kidney disease.

H W Xu1, Sheng Qiang Yu, Chang Lin Mei, Ming Hua Li.   

Abstract

BACKGROUND AND
PURPOSE: the association of autosomal-dominant polycystic kidney disease (ADPKD) with intracranial aneurysm (ICAN) is well known but little is known about the characteristics of ICAN in ADPKD. The purpose of this study was to investigate the prevalence and characteristics of ICAN in ADPKD.
METHODS: we screened 355 patients with ADPKD (mean age, 46.5 ± 13.2 years; range, 7 to 87 years) with 3-dimensional time-of-flight MR angiography. Size, location, and morphology of aneurysms were assessed. The prevalence and characteristics of ICAN in patients with ADPKD were evaluated. Patients with ICAN found by MR angiography and moderate renal function subsequently were recommended to undergo digital subtraction angiography for comparison.
RESULTS: the prevalence of ICAN in ADPKD was 12.4% (95% CI, 8.95% to 15.82%) with an equal gender distribution. The prevalence increased as age increased, reaching a peak value of 23.3% (95% CI, 16.85 to 29.75%) in the 60- to 69-year age group. The prevalence of ICAN in patients with ADPKD with a positive family history of hemorrhagic stroke or ICAN was higher than patients with ADPKD lacking such family history (relative risk, 1.968; 95% CI, 1.57 to 2.67). The mean diameter of ICAN was 3.85 ± 3.25 mm. The most frequent site of ICAN was the internal carotid artery. The result of digital subtraction angiography of 15 patients with 18 ICANs and moderate renal function corresponded to the detection of MR angiography.
CONCLUSIONS: the characteristics of ICAN in patients with ADPKD were different from some previous reports. Systematic screening of ICAN with 3-dimensional time-of-flight MR angiography is recommended for patients with ADPKD, particularly for adult patients (≧30 years) or patients with a positive family history of hemorrhagic stroke or ICAN.

Entities:  

Mesh:

Year:  2010        PMID: 21164130     DOI: 10.1161/STROKEAHA.110.578740

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  49 in total

1.  Treatment of Unruptured Intracranial Aneurysms in Autosomal Dominant Polycystic Kidney Disease: Primum Non Nocere.

Authors:  M Niemczyk
Journal:  AJNR Am J Neuroradiol       Date:  2015-10-15       Impact factor: 3.825

2.  Presymptomatic Screening for Intracranial Aneurysms in Patients with Autosomal Dominant Polycystic Kidney Disease.

Authors:  Irina M Sanchis; Shehbaz Shukoor; Maria V Irazabal; Charles D Madsen; Fouad T Chebib; Marie C Hogan; Ziad El-Zoghby; Peter C Harris; John Huston; Robert D Brown; Vicente E Torres
Journal:  Clin J Am Soc Nephrol       Date:  2019-07-30       Impact factor: 8.237

Review 3.  Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases.

Authors:  Bassam Abu-Wasel; Caolan Walsh; Valerie Keough; Michele Molinari
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

Review 4.  An approach to cystic kidney diseases: the clinician's view.

Authors:  Christine E Kurschat; Roman-Ulrich Müller; Mareike Franke; David Maintz; Bernhard Schermer; Thomas Benzing
Journal:  Nat Rev Nephrol       Date:  2014-09-30       Impact factor: 28.314

5.  Screening for Intracranial Aneurysms in Patients with Autosomal Dominant Polycystic Kidney Disease.

Authors:  Adrien Flahault; Dominique Joly
Journal:  Clin J Am Soc Nephrol       Date:  2019-06-19       Impact factor: 8.237

Review 6.  Autosomal dominant polycystic kidney disease in children.

Authors:  Melissa A Cadnapaphornchai
Journal:  Curr Opin Pediatr       Date:  2015-04       Impact factor: 2.856

7.  Prevalence of cardiovascular events in patients with autosomal dominant polycystic kidney disease.

Authors:  Imed Helal; Berenice Reed; Pamela Mettler; Kim Mc Fann; Oleksandra Tkachenko; Xiang-Dong Yan; Robert W Schrier
Journal:  Am J Nephrol       Date:  2012-10-04       Impact factor: 3.754

8.  Intracranial aneurysms in autosomal dominant polycystic kidney disease.

Authors:  M Niemczyk; M Gradzik; S Niemczyk; M Bujko; M Gołębiowski; L Pączek
Journal:  AJNR Am J Neuroradiol       Date:  2013-02-28       Impact factor: 3.825

Review 9.  Management of Unruptured Intracranial Aneurysms.

Authors:  Deena M Nasr; Robert D Brown
Journal:  Curr Cardiol Rep       Date:  2016-09       Impact factor: 2.931

Review 10.  "Sit back, observe, and wait." Or is there a pharmacologic preventive treatment for cerebral aneurysms?

Authors:  Marcelo M Valença
Journal:  Neurosurg Rev       Date:  2012-10-16       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.